Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits.
about
Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson's DiseaseOxidative stress and Parkinson's diseaseSigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neuronsNeuroprotective Effects of Salidroside in the MPTP Mouse Model of Parkinson's Disease: Involvement of the PI3K/Akt/GSK3β PathwayRats overexpressing the dopamine transporter display behavioral and neurobiological abnormalities with relevance to repetitive disordersMisassembly of full-length Disrupted-in-Schizophrenia 1 protein is linked to altered dopamine homeostasis and behavioral deficits.Genome-wide transcriptome analysis of hypothalamus in rats with inherited stress-induced arterial hypertension.Physical exercise prevents motor disorders and striatal oxidative imbalance after cerebral ischemia-reperfusionAge-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice.Ionomycin-induced calcium influx induces neurite degeneration in mouse neuroblastoma cells: analysis of a time-lapse live cell imaging system.Harnessing the trophic and modulatory potential of statins in a dopaminergic cell line.Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.Vesicular Monoamine Transporter 2 (VMAT2) Level Regulates MPTP Vulnerability and Clearance of Excess Dopamine in Mouse Striatal Terminals.Antioxidant-Mediated Modulation of Protein Reactivity for 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopamine Metabolite.Selective and Mechanically Robust Sensors for Electrochemical Measurements of Real-Time Hydrogen Peroxide Dynamics in Vivo.Unpredictable chronic mild stress differentially impairs social and contextual discrimination learning in two inbred mouse strains.Effects of decreased dopamine transporter levels on nigrostriatal neurons and paraquat/maneb toxicity in mice.Epothilone B Benefits Nigrostriatal Pathway Recovery by Promoting Microtubule Stabilization After Intracerebral Hemorrhage.Tyrosine Hydroxylase, Vesicular Monoamine Transporter and Dopamine Transporter mRNA Expression in Nigrostriatal Tissue of Rats with Pedunculopontine Neurotoxic Lesion.Neuroprotective Role of Astroglia in Parkinson Disease by Reducing Oxidative Stress Through Dopamine-Induced Activation of Pentose-Phosphate Pathway.Epothilone B Benefits Nigral Dopaminergic Neurons by Attenuating Microglia Activation in the 6-Hydroxydopamine Lesion Mouse Model of Parkinson's Disease
P2860
Q26750370-6A6190BE-6B73-404D-907D-E78FB0F3E0EDQ26798897-5400C25E-C554-44D4-8D62-EE054907E3FDQ27330088-666B7584-B81A-48FC-B25A-3A17F3F186B7Q28390865-C42948D3-3EEF-4289-9990-CAA7FC25F96DQ30367670-46992E7E-C572-4896-B60B-E589AE332B86Q30826347-A6E9A0F2-F9E7-4F01-B5FC-85F1C5C6DCACQ35907627-40D2D35F-A0EF-4A88-BCCB-AD45D91CEA08Q36057214-1ABE1F7D-9E7B-4F2D-805E-D7742F22A516Q37701053-AC779435-F62B-459A-9766-391FF57BE3FFQ38749124-BEF7B0E8-6935-4B30-9C02-60BBB04A3D57Q38809645-DB1E1B81-FF81-4ED9-A08F-DBA309BE18FEQ38926644-DEC04F64-67CB-4471-97A9-4AE161FF3D70Q41031814-FC62990A-9BDF-4B2F-93E7-E8C37F23D504Q42196555-72C75409-F3AF-4877-8271-4E417E197D29Q46250927-FE92FC3D-6E05-4060-8896-666E17CB4C0DQ47105562-48A6D0D2-334F-4FC8-B5ED-3015311A38BCQ48377173-854D8C46-AD83-4462-82F7-2205CA4057C1Q48506586-6FEE39FE-1798-4C6F-BC1C-D7F9A6DE13CAQ49490658-30F768F6-72DB-4450-8971-24235EF8CBCDQ55450592-F98D4BD7-C42B-4FC7-9987-64E94F548017Q57490051-CA91374D-CE10-4B2E-BF29-C88DF889710A
P2860
Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Increased expression of the do ...... DOPA reversible motor deficits
@nl
Increased expression of the do ...... OPA reversible motor deficits.
@ast
Increased expression of the do ...... OPA reversible motor deficits.
@en
type
label
Increased expression of the do ...... DOPA reversible motor deficits
@nl
Increased expression of the do ...... OPA reversible motor deficits.
@ast
Increased expression of the do ...... OPA reversible motor deficits.
@en
prefLabel
Increased expression of the do ...... DOPA reversible motor deficits
@nl
Increased expression of the do ...... OPA reversible motor deficits.
@ast
Increased expression of the do ...... OPA reversible motor deficits.
@en
P2093
P2860
P50
P3181
P1476
Increased expression of the do ...... DOPA reversible motor deficits
@en
P2093
A Salahpour
L T Nguyen
M K Bermejo
M M Hossain
R M Wightman
S T Masoud
T D Sotnikova
P2860
P3181
P356
10.1016/J.NBD.2014.10.016
P407
P577
2014-10-30T00:00:00Z